載入...
β2-adrenoreceptor medications and risk of Parkinson disease
OBJECTIVE: A recent study observed a two-fold greater risk of Parkinson disease (PD) in relation to the β2-adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the β2-adrenoreceptor agonist salbutamol. We examined whether confounding by clinical indication for these medications,...
Na minha lista:
| 發表在: | Ann Neurol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881195/ https://ncbi.nlm.nih.gov/pubmed/30225948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25341 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|